Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 7Recruiting 6Completed 5Not yet recruiting 3Terminated 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Observational 4Interventional 1

Sponsor

Cancer Type

Thoracic 1Plasma cell 1Gynecologic 1Genitourinary 1

Conditions

Tuberous Sclerosis 1Smoldering Multiple Myeloma 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Monoclonal Gammopathy of Undetermined Significance 1Lymphangioleiomyomatosis 1Lung Neoplasms 1Disease 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Urination × Clear all
NCT03951220 2025-08-19

LOOMIS

Oxford University Hospitals NHS Trust

Completed
67 enrolled 24 charts
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Neoplasms, Plasma Cell

NCT03831230 2025-08-08

OVAREX

Centre Francois Baclesse

Completed
250 enrolled
Gynecologic

Ovarian Neoplasms

NCT05323370 2023-03-29

LAM-CAK

University Hospital, Tours

Completed
19 enrolled

Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT03730324 2023-03-23

ProBioM

Odense University Hospital

Phase NA Completed
261 enrolled
Genitourinary

Disease, Prostatic Neoplasms

NCT01785342 2022-03-15

DECAMP-1

Boston University

Completed
489 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡